Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3361404
Max Phase: Preclinical
Molecular Formula: C41H56N6O10S
Molecular Weight: 825.00
Molecule Type: Small molecule
Associated Items:
ID: ALA3361404
Max Phase: Preclinical
Molecular Formula: C41H56N6O10S
Molecular Weight: 825.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSCC[C@H](NC(=O)[C@@H](/C=C/CNC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)CC(C)C)C(N)=O
Standard InChI: InChI=1S/C41H56N6O10S/c1-26(2)22-29(38(54)45-30(37(42)53)19-21-58-4)16-11-20-43-40(56)33(24-28-14-9-6-10-15-28)47(3)41(57)32(23-27-12-7-5-8-13-27)46-39(55)31(25-36(51)52)44-34(48)17-18-35(49)50/h5-16,26,29-33H,17-25H2,1-4H3,(H2,42,53)(H,43,56)(H,44,48)(H,45,54)(H,46,55)(H,49,50)(H,51,52)/b16-11+/t29-,30-,31-,32-,33-/m0/s1
Standard InChI Key: MMGMPBHKVDMGED-SEBHWXEDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 825.00 | Molecular Weight (Monoisotopic): 824.3779 | AlogP: 1.67 | #Rotatable Bonds: 26 |
Polar Surface Area: 254.40 | Molecular Species: ACID | HBA: 9 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.62 | CX Basic pKa: | CX LogP: 1.57 | CX LogD: -4.77 |
Aromatic Rings: 2 | Heavy Atoms: 58 | QED Weighted: 0.07 | Np Likeness Score: 0.11 |
1. Misu R, Oishi S, Yamada A, Yamamura T, Matsuda F, Yamamoto K, Noguchi T, Ohno H, Okamura H, Ohkura S, Fujii N.. (2014) Development of novel neurokinin 3 receptor (NK3R) selective agonists with resistance to proteolytic degradation., 57 (20): [PMID:25247671] [10.1021/jm500771w] |
Source(1):